Staged identification of CAP in fever patients across epidemic environments: modeling & validation

在流行环境下对发热患者进行社区获得性肺炎分阶段识别:建模与验证

阅读:1

Abstract

Diagnosing community-acquired pneumonia (CAP) relies on costly imaging, posing challenges in resource-limited settings. Traditional tools focus on diagnostic tests for clinicians rather than patient use. Additionally, classification of subtypes in traditional Chinese medicine (TCM) lacks criteria. We developed a multimodal fusion model using machine learning algorithms and clinical variables from basic information, medical records, and lab tests to assess CAP risk in fever patients. The model integrates top-performing models via ensemble learning to predict pneumonia probability. We trained on 2,193 visits at Beijing Traditional Chinese Medicine Hospital's fever clinic from Dec 2021 to Dec 2022, and validated on 300 visits from Jan to July 2024. Use unsupervised learning to classify subtypes. The training cohort included 1,781 CAP and similar patients, with 210 in the external validation cohort. CAPs were diagnosed via chest CT. The α model, based on pre-visit medical records, performed well (AUC(internal)=0.80, 95%CI 0.77-0.83; AUC(external)=0.80, 95%CI 0.71-0.87). The β model added four lab indicators, optimizing performance (AUC(internal)=0.93, 95%CI 0.92-0.95; AUC(external)=0.81, 95%CI 0.70-0.90). Two models were developed into online calculators. Latent class analysis distinguished Cold/Heat syndrome as subtypes. Despite the single-center, retrospective design, two final models performed good for identifying CAP across epidemic environments.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。